Pakistani (KSE) Healthcare Sector Analysis
UpdatedMay 12, 2022
DataAggregated Company Financials
Companies13
- 7D-5.4%
- 3M-11.7%
- 1Y-19.7%
- YTD-12.8%
Over the last 7 days, the Healthcare industry has dropped 3.2%, driven by a pullback from Abbott Laboratories (Pakistan) of 2.6%. Meanwhile, Otsuka Pakistan actually outperformed within the industry, gaining 7.8% in the last week. Overall the industry is down 18% in 12 months. As for the next few years, earnings are expected to grow by 20% per annum.
Sector Valuation and Performance
Has the Pakistani Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Thu, 12 May 2022 | PK₨233.3b | PK₨184.3b | PK₨22.9b | 9.5x |
| Sat, 09 Apr 2022 | PK₨251.4b | PK₨182.8b | PK₨22.9b | 10.4x |
| Mon, 07 Mar 2022 | PK₨254.9b | PK₨180.0b | PK₨21.1b | 11.6x |
| Wed, 02 Feb 2022 | PK₨266.0b | PK₨180.0b | PK₨21.5b | 11.8x |
| Fri, 31 Dec 2021 | PK₨268.4b | PK₨180.0b | PK₨21.5b | 12x |
| Sun, 28 Nov 2021 | PK₨267.7b | PK₨179.9b | PK₨21.5b | 12.2x |
| Tue, 26 Oct 2021 | PK₨291.4b | PK₨173.9b | PK₨20.7b | 14.7x |
| Thu, 23 Sep 2021 | PK₨291.4b | PK₨170.6b | PK₨19.1b | 15.4x |
| Sat, 21 Aug 2021 | PK₨313.7b | PK₨170.6b | PK₨19.1b | 19.4x |
| Sat, 05 Jun 2021 | PK₨291.0b | PK₨157.5b | PK₨17.3b | 17x |
| Tue, 09 Mar 2021 | PK₨305.6b | PK₨151.9b | PK₨15.5b | 16.7x |
| Mon, 30 Nov 2020 | PK₨280.5b | PK₨148.4b | PK₨13.6b | 21.2x |
| Thu, 03 Sep 2020 | PK₨296.8b | PK₨142.0b | PK₨12.3b | 25.8x |
| Sun, 07 Jun 2020 | PK₨236.5b | PK₨141.3b | PK₨10.7b | 19.1x |
| Sat, 29 Feb 2020 | PK₨208.6b | PK₨138.5b | PK₨10.0b | 20.7x |
| Tue, 03 Dec 2019 | PK₨221.7b | PK₨133.9b | PK₨9.9b | 18.9x |
| Fri, 06 Sep 2019 | PK₨133.7b | PK₨132.1b | PK₨10.1b | 12.5x |
| Mon, 10 Jun 2019 | PK₨170.1b | PK₨127.9b | PK₨10.5b | 15.9x |
Median PE Ratio
15.9x
Current Industry PE
- Investors are more pessimistic on the industry, indicating that they anticipate long-term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 9.6x which is lower than its 3-year average PE of 17.0x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 30% per year over the last three years.
- Revenues for these companies have grown 13% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Pakistani Healthcare sector?
| PK Market | -5.47% | |
| Healthcare | -5.36% | |
| Medical Equipment | 0% | |
| Healthtech | 0% | |
| Biotech | 0% | |
| Healthcare Services | -2.53% | |
| Pharma | -5.12% | |
| Life Sciences | -15.33% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry even though it's trading below its 3-year average PE ratio of 28.9x.
- It looks like they are confident that earnings will grow faster in the future than they have historically.
- Investors are most pessimistic about the Healthcare Services industry, which is trading below its 3-year average of 993x.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 20% over the next 5 years.
- However this is lower than its past earnings growth rate of 51% per year.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| OTSU Otsuka Pakistan | PK₨248.99 | 7.8% +PK₨217.7m | n/a | PS7.6x | |
| SHFA Shifa International Hospitals | PK₨181.00 | 0.4% +PK₨45.5m | -8.6% | PS9.5x |